Revenue: The sum of all revenue fields included for a company's operating activities.
Minerva Neurosciences, Inc (NERV) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
-- |
$1.44M |
|
-- |
|
-- |
|
$21.85M |
|
$-21.85M |
|
$23.29M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$-21.85M |
|
$-21.83M |
|
7.57M |
|
7.57M |
|
$0.19 |
|
$0.19 |
|
Balance Sheet Financials | |
$22.27M |
|
$0.01M |
|
$14.87M |
|
$37.14M |
|
$2.84M |
|
-- |
|
$60.00M |
|
$62.84M |
|
$-25.69M |
|
$-40.56M |
|
$-25.69M |
|
6.99M |
|
Cash Flow Statement Financials | |
$-19.55M |
|
-- |
|
-- |
|
$41.01M |
|
$21.46M |
|
$-19.55M |
|
$1.33M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.60% |
|
-3.55% |
|
3.87% |
|
-5.60% |
|
$-3.67 |
|
$-2.58 |
|
$-2.58 |